ARCHIVES

US Oncology Begins Trial Of Taxotere And Xeloda

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

DCPC Board Approves “Working” Guidelines For Early Detection

October 2, 1987

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s

May 23, 1980